Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein

https://cmfrc.tums.ac.ir/article/bevacizumab-inhibits-angiogenic-cytokines-in-head-and-neck-squamous-cell-carcinoma:-from-gene-to-the-protein

bevacizumab, a vascular endothelial growth (VEGF) factor monoclonal antibody on HNSCC cells in vitro to evaluate angiogenic profile changes. Materials and Methods: HNSCC cells were grown and after that different concentrations of bevacizumab were added in...